<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND AIM OF THE STUDY: Surgical aortic root reconstruction techniques are standard therapy to avoid catastrophic vascular events in patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> with a dilated and/or dissected aortic root </plain></SENT>
<SENT sid="1" pm="."><plain>The study aim was to evaluate the long-term results of aortic root reconstruction </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Eighty-three patients (54 males, 29 females; mean age 37+/-17 years) fulfilling strict Ghent criteria for <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> underwent aortic root surgery between 1971 and 2001 </plain></SENT>
<SENT sid="3" pm="."><plain>Of these patients, 65 (78%) underwent a composite valve conduit repair and 18 (22%) a valve-sparing aortic root reconstruction </plain></SENT>
<SENT sid="4" pm="."><plain>Six patients (7%) suffered from an <z:hpo ids='HP_0011009'>acute</z:hpo> type A dissection, and 16 (19%) a <z:hpo ids='HP_0011010'>chronic</z:hpo> type A dissection </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: In-hospital and 30-day mortality was 3.6% (n = 3) </plain></SENT>
<SENT sid="6" pm="."><plain>Morbidity included <z:hpo ids='HP_0001297'>stroke</z:hpo> (1.2%; n = 1), perioperative <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> (1.2%; n = 1) and reoperation for <z:mp ids='MP_0001914'>bleeding</z:mp> (10%; n = 8) </plain></SENT>
<SENT sid="7" pm="."><plain>Of 21 late <z:hpo ids='HP_0011420'>deaths</z:hpo>, the cause was cardiac in nine cases </plain></SENT>
<SENT sid="8" pm="."><plain>Actuarial survival at 5, 10, 15 and 20 years was 84% (95% CI 76-93%), 73% (CI 61-86%), 59% (CI 45-77%) and 43% (CI 26-72%), respectively </plain></SENT>
<SENT sid="9" pm="."><plain>Multivariate predictors for late <z:hpo ids='HP_0011420'>death</z:hpo> were postoperative dysrhythmias and need for inotropes (p &lt; or =0.01) </plain></SENT>
<SENT sid="10" pm="."><plain>Freedom from reoperation at 5, 10, 15 and 20 years was 86% (CI 78-95%), 69% (CI 56-85%), 53% (CI 38-74%) and 48% (CI 23-71%), respectively </plain></SENT>
<SENT sid="11" pm="."><plain>Multivariate predictors for reoperation were preoperative <z:hpo ids='HP_0001634'>mitral valve prolapse</z:hpo> and an initial valve-sparing aortic procedure (p &lt; or =0.05) </plain></SENT>
<SENT sid="12" pm="."><plain>In the composite valve conduit patients, freedom from <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> was 88% (CI 76-100%), and from <z:hpo ids='HP_0100584'>endocarditis</z:hpo> was 99% (CI 93-100%) at 15 years </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSION: Composite valve conduit replacement of the aortic root in patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> offers a durable result, with low mortality and long-term complication rates </plain></SENT>
<SENT sid="14" pm="."><plain>Reoperation was most commonly required for cardiac and <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> unrelated to the initial operation and in patients undergoing a valve-sparing aortic root procedure </plain></SENT>
</text></document>